Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberWO2004002419 A3
Publication typeApplication
Application numberPCT/US2003/020408
Publication date3 Jun 2004
Filing date27 Jun 2003
Priority date27 Jun 2002
Also published asCA2492060A1, CA2492060C, CN1678305A, CN101898995A, CN101898995B, CN103254114A, CN103288714A, CN103288715A, CN103333099A, EP1534270A2, EP1534270A4, US7268156, US7626041, US7759384, US7893100, US7902378, US20050240027, US20070238774, US20070244181, US20070244182, US20070259940, US20080262069, WO2004002419A2
Publication numberPCT/2003/20408, PCT/US/2003/020408, PCT/US/2003/20408, PCT/US/3/020408, PCT/US/3/20408, PCT/US2003/020408, PCT/US2003/20408, PCT/US2003020408, PCT/US200320408, PCT/US3/020408, PCT/US3/20408, PCT/US3020408, PCT/US320408, WO 2004/002419 A3, WO 2004002419 A3, WO 2004002419A3, WO-A3-2004002419, WO2004/002419A3, WO2004002419 A3, WO2004002419A3
InventorsChristopher S Brook, Wei Chen, Orco Philip C Dell, Lee M Katrincic, Ann Marie Louvet, Choon K Oh, Paul G Spoors, Christopher Werner
ApplicantChristopher S Brook, Wei Chen, Orco Philip C Dell, Lee M Katrincic, Ann Marie Louvet, Choon K Oh, Sb Pharmco Inc, Paul G Spoors, Christopher Werner
Export CitationBiBTeX, EndNote, RefMan
External Links: Patentscope, Espacenet
Carvedilol phosphate salts and/or solvates thereof, correspondinq compositions, and/or methods of treatment
WO 2004002419 A3
Abstract
The present invention relates to carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.), and/or solvates thereof, compositions containing the aforementioned salts and/or solvates, and methods of using the aforementioned salts and/or solvates to treat hypertension, congestive heart failure and angina, etc.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
WO2001087837A1 *3 May 200122 Nov 2001A/S Gea Farmaceutisk FabrikProcess and intermediates for the preparation of 1-(9h-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)-ethylamino]-propan-2-ol, carvedilol or acid addition salts thereof
Non-Patent Citations
Reference
1 *See also references of EP1534270A2
Classifications
International ClassificationC07D209/82, C07D209/88, A61K31/403, A61P9/00, A61P9/04, A61P9/12
Cooperative ClassificationC07D209/88
European ClassificationC07D209/88
Legal Events
DateCodeEventDescription
8 Jan 2004ALDesignated countries for regional patents
Kind code of ref document: A2
Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG
8 Jan 2004AKDesignated states
Kind code of ref document: A2
Designated state(s): AE AG AL AU BA BB BR BZ CA CN CO CR CU DM DZ EC GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MA MG MK MN MX NO NZ OM PH PL RO SC SG TN TT UA US UZ VN YU ZA
10 Mar 2004121Ep: the epo has been informed by wipo that ep was designated in this application
26 Aug 2004DFPERequest for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
10 Dec 2004WWEWipo information: entry into national phase
Ref document number: 200410011
Country of ref document: ZA
Ref document number: 2004/10011
Country of ref document: ZA
13 Dec 2004WWEWipo information: entry into national phase
Ref document number: 537161
Country of ref document: NZ
Ref document number: 2003248746
Country of ref document: AU
16 Dec 2004WWEWipo information: entry into national phase
Ref document number: 10518654
Country of ref document: US
Ref document number: 165814
Country of ref document: IL
17 Dec 2004WWEWipo information: entry into national phase
Ref document number: PA/a/2004/012923
Country of ref document: MX
Ref document number: 2492060
Country of ref document: CA
20 Dec 2004WWEWipo information: entry into national phase
Ref document number: 1-2004-502085
Country of ref document: PH
24 Dec 2004WWEWipo information: entry into national phase
Ref document number: 1020047021135
Country of ref document: KR
27 Dec 2004WWEWipo information: entry into national phase
Ref document number: 2004518025
Country of ref document: JP
17 Jan 2005WWEWipo information: entry into national phase
Ref document number: 2003762176
Country of ref document: EP
25 Feb 2005WWEWipo information: entry into national phase
Ref document number: 20038202301
Country of ref document: CN
3 Mar 2005WWPWipo information: published in national office
Ref document number: 1020047021135
Country of ref document: KR
1 Jun 2005WWPWipo information: published in national office
Ref document number: 2003762176
Country of ref document: EP
29 May 2007ENPEntry into the national phase in:
Ref document number: PI0312102
Country of ref document: BR
16 Sep 2008WWEWipo information: entry into national phase
Ref document number: 12008502076
Country of ref document: PH